Navigation Links
Cord Blood America, Inc. Announces 2009 First Quarter Results
Date:5/21/2009

whose samples were stored during the year.

"During the first quarter, we took significant initiatives to position the Company for growth," said Matthew Schissler, Founder and CEO. "We shifted our business focus to capitalize on the opportunities in the processing of umbilical cord blood, deemphasizing the advertising business, as reflected by our improved gross margin. We believe that the new administration will further support growth in the stem cell industry, and in our business of collecting and storing umbilical cord blood lifting the current ban on Federal funding for research on embryonic stem cell lines. The funding should accelerate the use of stem cells in treating diabetes, heart disease, and other major diseases, driving consumers to make the investments in storage and collection."

"We also strengthened our balance sheet, reducing indebtedness, extending maturities and regaining compliance with all of our key lenders," continued Schissler. "We believe with our improved financial condition that Cord Blood America is now well-positioned to consolidate the industry as well as to acquire or build its own state-of-the-art laboratory for the storage of multiple stem cell products including umbilical cord blood stem cells, which should further improve gross margin and profitability. We believe that the Company is well positioned to play a key role as stem cell therapies become a viable treatment modality."

Conference Call:

The Company will hold a conference call at 11 a.m. eastern time today to discuss the results and outlook for the balance of the year. Interested parties may access the call by dialing 877-627-6555 (domestically) or 719-325-4931 (internationally) and referencing passcode 3112433. There will also be a replay of the call available for five days at the conclusion of the call. Parties desiring to listen to the replay may dial 888-203-1112 (domestically
'/>"/>

SOURCE Cord Blood America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Research points to a new way to protect kidneys threatened by insufficient blood or toxins
2. Cord Blood America CEO Matthew Schissler Expands on Thought Process in Owning Stem Cell Laboratory
3. Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes
4. Viral Infection Might Trigger High Blood Pressure
5. Cord Blood America Receives Commitment for $2.3 Million to Fund Its Own Stem Cell Laboratory
6. New research confirms milestone study on blood pressure meds
7. AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure
8. Study finds iron levels not predictive of survival for form of blood cancer
9. Genes Yield Clues to High Blood Pressure
10. Photo: Levemir(R) Once-Daily Substantially Lowered Average Blood Sugar Levels of Patients with Type 2 Diabetes in TITRATE(R) Study
11. Too-Low Blood Pressure Can Also Bring Danger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... 2015 , ... Good health and a good cause paired up at The ... BCBSNJ) donated $11,000 to the New Jersey Golf Foundation through its Healthy Steps Challenge. ... The Barclays, Horizon BCBSNJ challenged PGA TOUR golfer and NJ native Morgan Hoffmann to ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... of 200 food banks in commemorating “Hunger Action Month” during the entire month ... mobilization, the Food Bank will be dedicating its efforts this September to an ...
(Date:9/2/2015)... ... 2015 , ... Ericson is a noted speaker and educator in the field ... of Education for the Association for Clinical Documentation Improvement Specialists (ACDIS) where she developed ... She serves as a CDI subject matter expert for a variety of HCPro and ...
(Date:9/2/2015)... MN (PRWEB) , ... September 02, 2015 , ... Every ... to it; others dread it. However, few are prepared to face the academic workload ... school starts. Our schools haven’t prepared them since schools don’t teach students how to ...
(Date:9/2/2015)... , ... September 02, 2015 , ... Amada Senior Care, ... office in Kansas – its Johnson County location. Amada franchise partners Mike ... has a registered nurse background and spent over 20 years in medical device sales ...
Breaking Medicine News(10 mins):Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 2Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 3Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 2Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 3Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 4Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 3Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 4Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 3Health News:Amada Senior Care Expands to Greater Kansas City 2
... of Americans want no changes to the health care legislation ... may be more common ground with other Americans than many ... Indiana University,s Center for Health Policy and Professionalism Research (CHPPR). ... the new law:, 21 percent said they were completely ...
... heart-related conditions, researchers say , SATURDAY, April 24 ... with noncardiac (not heart-related) chest pain may require ... receive, a new study has found. , Noncardiac ... of problems, including panic attack, musculoskeletal pain, gastroesophageal ...
... ZSL, a ... new Business Power Cloud & Mobile Add-on Suite for Microsoft Dynamics CRM and ERP applications – ... ... a leading ISV and Microsoft Gold Certified Partner based out of Edison, New Jersey, today launched ...
... ... to existing training programs, and group portal access for clinical research studies., , ... Dallas, TX (PRWEB) April ... of CORE (TM) ( http://core.medtrials.com ). CORE (TM) stands for Clinical research Online ...
... ... celebrates 25th anniversary as leading off-utility industrial power supplier , ... Tulsa, OK (PRWEB) April 24, 2010 -- ... as a financially secure American company by opening our 7th industrial power location in ...
... , ... All My Children star for her work on behalf of Parkinson,s research ... East Islip, NY (PRWEB) April 24, 2010 ... philanthropist, a corporation and a person afflicted by the disease who have come together to find ...
Cached Medicine News:Health News:More common ground in health care reform law disagreement than meets the eye 2Health News:Noncardiac Chest Pain May Warrant More Management: Study 2Health News:ZSL Launches Cloud & Mobile Add-on Suites for Microsoft Dynamics ERP and CRM Applications 2Health News:ZSL Launches Cloud & Mobile Add-on Suites for Microsoft Dynamics ERP and CRM Applications 3Health News:MedTrials Launches New Online Training Website: http://core.medtrials.com 2Health News:Emmy-Award Winning Actress Susan Lucci to Receive Philanthropic Leadership Award at 7th Annual Cure for Sure Dinner 2Health News:Emmy-Award Winning Actress Susan Lucci to Receive Philanthropic Leadership Award at 7th Annual Cure for Sure Dinner 3
(Date:9/2/2015)... Advanced Wound Dressings - SA Analysis ... have steadily replaced traditional bandages and gauze materials ... indications, such as trauma wounds, burns, and chronic ... protection become increasingly critical in wound healing, advanced ... This report focuses on nine market categories ...
(Date:9/2/2015)... NEW YORK , Sept. 2, 2015 /PRNewswire/ ... dystrophy is an X-linked disease, which generally affects ... muscle degeneration and weakness. The disease is caused ... result in the lack of production of dystrophin ... in individuals. The lack of dystrophin weakens muscle ...
(Date:9/2/2015)... --  About ELISA test ELISA test is ... used for measuring the concentration of analytes such as ... types of enzymes such as carbonic anhydrase, glucose oxidase, ... photometry or fluorometry. ELISA is used as a screening ... as HIV, pernicious anemia, rotavirus, Rocky Mountain spotted fever, ...
Breaking Medicine Technology:Advanced Wound Dressings - SA Analysis and Market Forecasts 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 3
... Columbia, March 25, Astellas Pharma US, Inc. and ... ; TSX: COM) announced the first,pivotal Phase III ... was published today in Circulation,the official journal of ... known as the Atrial arrhythmia Conversion Trial (ACT ...
... in 2009, SEATTLE, March 25 Cell Therapeutics, ... enrollment is complete in,the phase III EXTEND (PIX301) clinical ... B cell non-Hodgkin,s lymphoma (NHL).,An analysis of the data ... on,prior discussions with the U.S. Food and Drug Administration ...
Cached Medicine Technology:Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm 2Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm 3Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm 4Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm 5Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 2Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 3Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 4
... The Featured Products ... at Mediflex and are ... modular in regular or ... come equipped with insulation, ...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: